| Literature DB >> 27468395 |
Li Pan1, Yuan Zhao1, Zhijie Yuan1, Guixin Qin1.
Abstract
Integrins are an important family of adhesion molecules that were first discovered two decades ago. Integrins are transmembrane heterodimeric glycoprotein receptors consisting of α and β subunits, and are comprised of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. Therein, integrin cytoplasmic domains may associate directly with numerous cytoskeletal proteins and intracellular signaling molecules, which are crucial for modulating fundamental cell processes and functions including cell adhesion, proliferation, migration, and survival. The purpose of this review is to describe the unique structure of each integrin subunit, primary cytoplasmic association proteins, and transduction signaling pathway of integrins, with an emphasis on their biological functions.Entities:
Keywords: Adhesion; Associated proteins; Biological function; Integrin; Signal transduction pathway; Structure
Year: 2016 PMID: 27468395 PMCID: PMC4947080 DOI: 10.1186/s40064-016-2502-0
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Fig. 1Structure, primary cytoplasmic association proteins and biological functions of integrins
Structural characteristics and tissue distributions of α subunits
| Integrin subunits | Molecular weight (kDa) | Heterodimeric type | Structural characteristics | Tissue distributions | References |
|---|---|---|---|---|---|
| α1 | 210 | α1β1 | Has I-domain structure and heavily N-glycosylated when compared with other α chains | Embryo, liver, muscle, several inflammation tissues and epithelial cells | Isacke and Horton ( |
| α2 | 165 | α2β1 | Has I-domain structure and three cation binding sites | Epiderm in proliferation basal layer | Isacke and Horton ( |
| α3 | 130, 25 | α3β1 | No I-domain structure although has seven homologous repeated domains and most membrane proximal domains of α3, have divalent cation binding sites | Histological abnormalities of kidney, lungs, small skin blisters and glomerulus | Isacke and Horton ( |
| α4 | 150 | α4β1, α4β7 | No I-domain structure, otherwise extracellular portions of α4 have three EF-hand loop-like domains for divalent cations binding | Placenta and heart during embryogenesis, also in ladder smooth muscle cells | Isacke and Horton ( |
| α5 | 135, 25 | α5β1 | No I-domain structure, yet has five potential divalent cation binding sites | Embryo, vascellum, wound healing tissues and epithelial cells | Isacke and Horton ( |
| α6 | 120, 30 | α6β1, α6β4 | Structure is most homologous to integrin α3 | Platelet, basal surface of most epithelial cells, schwann cells, keratinocytes, prostate cancer cells and endothelial cells | Isacke and Horton ( |
| α7 | 100, 30 | α7β1 | No I-domain structure, otherwise proteolytically cleaved | Skeletal muscles, smooth muscles, cardiac muscle and nervous system | (Isacke and Horton |
| α8 | α8β1 | No I-domain structure, yet proteolytically cleaved | Smooth muscles, kidney and epithelial cells | Isacke and Horton ( | |
| α9 | α9β1 | No I-domain structure, still post-translationally cleaved | Intestinal epithelia, skin, muscles and liver | Isacke and Horton ( | |
| α10 | 160 | α10β1 | Structure is most homologous to integrin α1 and α2 | Heart and skeletal muscles | Hynes ( |
| α11 | α11β1 | The longest integrin α chain with 1166 amino acids and has I-domain structure, however has no GFFKR sequence | Adult uterus, heart and skeletal muscles | Zhang et al. ( | |
| αv | 125, 25 | αvβ1, αvβ3, αvβ5, αvβ6, αvβ8 | No I-domain structure, otherwise proteolytically cleaved | Neural crest cells, muscles, glial cells, epithelia, osteoclasts, and blood vessels during development or angiogenesis | Delannet et al. ( |
| αIIb | 125, 22 | αIIbβ3 | No I-domain structure, yet proteolytically cleaved | Human blood platelets and macrophagocyte | Isacke and Horton ( |
| αD | 150 | αDβ2 | Has I-domain structure | Tissue macrophages such as spleen and peripheral blood leucocytes | Isacke and Horton ( |
| αL | 180 | αLβ2 | Has I-domain structure and an imperfect MIDAS, with seven repetitive domains in extracellular domains | Leukocyte receptors | Shimaoka et al. ( |
| αM | 170 | αMβ2 | Has I-domain structure although not proteolytically cleaved, with five exposed loops surrounding MIDAS | Leukocyte receptors | Hee et al. ( |
| αX | 150 | αXβ2 | Has I-domain structure yet not proteolytically cleaved, with five exposed loops surrounding MIDAS | Leukocyte receptors | Isacke and Horton ( |
| αE | 150, 25 | αLβ7 | Has I-domain structure even proteolytically cleaved | Leukocyte receptors | Isacke and Horton ( |
Structural characteristics and tissue distributions of β subunits
| Integrin subunits | Molecular weight (kDa) | Heterodimeric type | Structural characteristics | Tissue distributions | References |
|---|---|---|---|---|---|
| β1 | 115 | α1β1, α2β1, α3β1, α4β1, α5β1, α6β1, α7β1, α8β1, α9β1, α10β1, α11β1, αvβ1 | Has 56 residues in four repeat regions and internally disulphide bounded | Widely distributed | Isacke and Horton ( |
| β2 | 95 | αDβ2, αLβ2, αMβ2, αXβ2 | Cytoplasmic tail contains eight potential phosphorylation sites | Leucocytes | Isacke and Horton ( |
| β3 | 105 | αvβ3, αIIbβ3 | Its Tyr 773 is potentially phosphorylated | Platelets and macrophages | Coppolino and Dedhar ( |
| β4 | 220 | α6β4 | Contains a large cytoplasmic domain approximately 1000 amino acids | Epithelial cells | Mercurio et al. ( |
| β5 | 100 | αvβ5 | Neural crest cells, blood vessels and tumors | Memmo and McKeown-Longo ( | |
| β6 | 105 | αvβ6 | Has a small cytoplasmic extension with unique 11 amino acids | Epithelial cells | Bandyopadhyay and Raghavan ( |
| β7 | 110 | α4β7, αEβ7 | Has two NPX(Y/F) motifs for potential tyrosine kinase binding | NK cells, B cells, eosinophils, intraepithelial cells, lymphocytes and peripheral cells | Schippers et al. ( |
| β8 | 95 | αvβ8 | No interact with cytoskeleton | Kidney, placenta, uterus, ovary and transformed cell lines | Isacke and Horton ( |
Integrin-associated proteins (cytoskeletal proteins)
| Cytoskeletal proteins | Binding sites to integrins | Functions | Roles in diseases | References |
|---|---|---|---|---|
| α-actinin | Central repeat of α-actinin can bind to integrin β1 and activated β2 | Enhancing signaling from matrix adhesion sites and stimulating integrin-mediated cell-to-matrix adhesion | Non-muscle α-actinins playing roles in the development and progression of cancer, such as metastatic breast, colorectal, pancreatic and ovarian cancer etc | Pavalk and LaRoche ( |
| Talin | Containing an atypical four point one protein, ezrin, radixin and moesin (FERM) domain that binding to integrin cytoplasmic tails | Important for transducing signals, actin network organization, focal adhesion composition, and integrin activation | Over expression leading the progression to metastatic disease such as prostate cancer | Desiniotis and Kyprianou ( |
| Filamin | Binding to integrin β tails | Important in integrin signaling transduction and the reorganization of the actin cytoskeleton | Mutation causing congenital anomalies and epileptic seizures | Feng and Walsh ( |
| Paxillin | Binding to the membrane proximal region of the integrin β1 | Acting as a crucial intermediary in the transduction of signals generated by cell adhesion through integrins | Has an association between Paxillin gene expression and invasive tumor behavior, including lung cancer and breast carcinoma etc | Schaller et al. ( |
| Tensin | Containing a PTB domain | Involved in integrin-mediated focal adhesions | Negativity producing unfavorable prognosis in terms of overall survival in breast cancer | Lo et al. ( |
Integrin-associated proteins (intracellular signaling proteins)
| Intracellular signaling proteins | Binding sites to integrins | Functions | Roles in diseases | References |
|---|---|---|---|---|
| Cytohesin-1 | Sec7 domain binds to cytoplasmic tail of integrin β2 | Affecting the PI3 K-dependent activation of integrin β2 | Regulating human polymorphonuclear neutrophil | Nagel et al. ( |
| FAK | Directly binding to integrin β1 tail | Playing an essential role in integrin-stimulated signaling mechanism | Important for tumor progression in cancer | Sun et al. ( |
| ILK | C-terminus of ILK binding to the cytoplasmic tails of integrin β1 and β3 | Regulating actin cytoskeleton by interacting with various actin-binding actin regulatory proteins and mediating the integrin-dependent signaling | Playing an important function to upregulate several types of cancers, as leukemia | Persad and Dedhar ( |
| β3-endonexin | Binding to integrin β3 cytoplasmic tail (Asn-IIe-Thr-Tyr (NITY) motif) | Increasing integrins affinity for ligand | Playing roles in proliferative disease, for example atherosclerosis. | Hannigan et al. ( |
| ICAP-1 | C-terminal region containing a PTB domain that providing a binding site for integrin β1 | Acting as a messenger that transmits information to the cellular nucleus for controlling gene expression and cell proliferation in a β1-independent manner | Important for body development and pathogenesis | Bouvard et al. ( |
| Rack1 | Interacting with the cytoplasmic tails of integrin β1, β2, and β5 | Important in the control of integrin-dependent PKC associated signaling cascades | Serving as a scaffold protein in promoting angiogenesis | Liliental and Chang ( |
| CIB | Interacting with integrin | Main function still needing to be tested in a cellular environment | Naik et al. ( |